AboutContact usRSS
dotsbydots
SEARCHCONTACT US

Buzz

Most popular

Daily
Weekly
1
Stars over Athens: The who’s who at Calcalist's first Israel-Greece conference
2
Wiz acquires Dazz for $450 million to strengthen AI-driven cloud security
3
Cyera doubles valuation to $3B with $300M Series D, total funding hits $600M in seven months
4
Mediaocean acquires Innovid for $500M, delisting it from the NYSE
5
Oracle CEO: "If we continue on our current trajectory, reaching a valuation of a trillion dollars is inevitable"
More news

Immunai

12 stories about Immunai
Noam Solomon Immunai

Immunai and Teva launch multi-tear AI collaboration for smarter drug development

14.11.24|CTech
The partnership will utilize Immunai’s cutting-edge immune system mapping tools to enhance precision in immunology and oncology trials.  
Noam Solomon Immunai

Immunai signs $18M collaboration with AstraZeneca to make cancer drug trials more efficient

26.09.24|Sophie Shulman
The collaboration will focus on clinical decision-making, including dose selection, elucidating mechanisms of action, patient responder vs. non-responder analysis, and biomarker identification, by leveraging the Israeli biotech unicorn’s AI model of the immune system. 
תחרות אטלס - תחרות סטארטאפים, חסות מדיה של כלכליסט תמונה של כל הזוכים

Atlas Awards: Robot and drone operating system developer XTEND wins big prize

16.05.24|Tomer Hadar
XTEND, founded in 2018 by Aviv and Matteo Shapira, Rubi Liani and Adir Tubi, developed a system that allows robots to be used in complex field missions instead of endangering soldiers; The winner in the innovation category: ForSight Robotics, which developed a robotic platform for eye surgery. Other winners: Immunai in the health category, AI21 in the artificial intelligence category, Claroty in industrial innovation and Optibus in the field of transportation 
כנס חוסן בהייטק AISRAEL - פאנל בריאות מימין אליחי וידל פרופ' רן בליצר דניאלה גלבוע נועם סולומון פרופ' איל צימליכמן

"Israel is a beacon for the world of advanced technology and AI in health"

14.04.24|Maya Nahum Shahal
Prof. Ran Balicer, Chief Innovation Officer at Clalit Health Services was speaking at the AIsrael conference on a panel on the impact of the AI revolution on the world of medicine. Prof. Eyal Zimlichman, Chief Transformation Officer & Chief Innovation Officer at Sheba Medical Center: "At the national level, the next decade must be dedicated to the field of artificial intelligence in healthcare"
Generative AI Chip

Holiday reading recommendation: 7 tech leaders using AI for social impact

11.04.23|Michael Matias and Betty Elbert
The recent calls to stop the development of systems based on artificial intelligence (AI) due to "fundamental risk to humanity" led us to return to interviews with several leaders who make a contribution to humanity thanks to AI technologies.
Noam Solomon Immunai

When not knowing is a methodology

05.01.22|Noam Solomon
"When your culture celebrates that knowledge always starts from the lack thereof, people are rewarded for asking the right questions and not just for knowing the answers," writes Noam Solomon, CEO & Co-Founder of Immunai
ועידת היוניקורנס Noam Solomon

“What we are building is the Google Maps for the human immune system”

16.12.21|James Spiro
Speaking at the Unicorn Forum, Noam Solomon, CEO of Immunai, outlined an exciting prospect for the future of human health
פורום היוניקורנס פאנל לצמוח למכור להנפיק מימין סופי שולמן הדר צייטלין עמית בן דב אור לנצ'נר ו נועם סולומון

Bright Data CEO: “We have crossed $100 million in annual revenue"

12.12.21|Maayan Manela
“We acquired three companies from the money in our account without requiring any external funding just this year,” said Or Lenchner, speaking on a panel with Gong CEO Amit Bendov, Immunai CEO Noam Solomon and Hailo’s Hadar Zeitlin
מייסדי Immunai מימין לואיס וולוך ו נועם סולומון

Biotech startup Immunai earns unicorn status with $215 million Series B

27.10.21|Meir Orbach
The Israeli company has developed a technological platform that maps the entire immune system for better detection, diagnosis, and treatment of disease
Luis Voloch

“The intersection of machine learning and biology is the future, and we want to be one of the first companies really helping push that forward.”

08.06.21|CTech
Luis Voloch joins Michael Matias to discuss how Immunai is reprograming our immune systems and improving the biology of our bodies
צביקה אורון ויולה ונצ'רס

Viola Ventures is Seeking Technologies that Combine AI and Fundamental Scientific Disciplines

02.06.20|Allon Sinai
After investing in Immunai, Zvika Orron is hungry for more of the same formula
מימין נועם סולומון ו לואיס וולוך

Immunai Announces $20 Million Seed Round to Fund Immune System Mapping

14.05.20|Hagar Ravet
The company employs more than 30 workers in Israel and New York and collaborates with more than 10 world-leading medical centers and bio-pharma companies